1. Hashimoto, Yosuke, Greene, Chris, Munnich, Arnold, Campbell, Matthew. 2023. The CLDN5 gene at the blood-brain barrier in health and disease. In Fluids and barriers of the CNS, 20, 22. doi:10.1186/s12987-023-00424-5. https://pubmed.ncbi.nlm.nih.gov/36978081/
2. Han, Lu, Cui, De-Jun, Huang, Bo, Lin, Guo-Yuan, Chen, Shao-Jie. 2023. CLDN5 identified as a biomarker for metastasis and immune infiltration in gastric cancer via pan-cancer analysis. In Aging, 15, 5032-5051. doi:10.18632/aging.204776. https://pubmed.ncbi.nlm.nih.gov/37286335/
3. Deshwar, Ashish R, Cytrynbaum, Cheryl, Murthy, Harsha, Dowling, James J, Weksberg, Rosanna. . Variants in CLDN5 cause a syndrome characterized by seizures, microcephaly and brain calcifications. In Brain : a journal of neurology, 146, 2285-2297. doi:10.1093/brain/awac461. https://pubmed.ncbi.nlm.nih.gov/36477332/
4. Omidinia, Eskandar, Mashayekhi Mazar, Fariba, Shahamati, Parima, Kianmehr, Anvarsadat, Shahbaz Mohammadi, Hamid. . Polymorphism of the CLDN5 gene and Schizophrenia in an Iranian Population. In Iranian journal of public health, 43, 79-83. doi:. https://pubmed.ncbi.nlm.nih.gov/26060683/
5. Hüls, Anke, Robins, Chloe, Conneely, Karen N, Epstein, Michael P, Wingo, Thomas S. 2021. Brain DNA Methylation Patterns in CLDN5 Associated With Cognitive Decline. In Biological psychiatry, 91, 389-398. doi:10.1016/j.biopsych.2021.01.015. https://pubmed.ncbi.nlm.nih.gov/33838873/
6. Wei, Jun, Hemmings, Gwynneth P. 2005. A study of the combined effect of the CLDN5 locus and the genes for the phospholipid metabolism pathway in schizophrenia. In Prostaglandins, leukotrienes, and essential fatty acids, 73, 441-5. doi:. https://pubmed.ncbi.nlm.nih.gov/16181776/
智鼠故事 
